2016 has demonstrated a busy year for Pharmacare, where several audits, acknowledgements and acquisitions were granted:
- This year has marked the 3rd renewal of the EU-GMP conducted by the Portugese Authority, INFARNED. Such a 3rd time renewal emphasized and reflected Pharmacare’s adherence by the stringent EU guidelines to good manufacturing practice, thereby further stressing the former’s quality reputation.
- Furthermore, the same year celebrated the 7th renewal of the Palestinian GMP further to consecutive successful audits beginning 2007. The Palestinian GMP audits were conducted on a yearly basis up until 2011, the system was changed, and a two-year auditing system was set beginning 2011.
- Finally, 2016 further witnessed the 1st renewal of the Belarus GMP conducted by the Belarus Ministry of Health. This authorisation applies to all Pharmacare products, from solid lines (tablets and capsules), to drug suspensions, semi-solid, creams, ointments, gels and liquid lines.
